Senior insider sale
ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$50.1K
2K shares
What this filing means
SANDERS CORAZON (CORSEE) D. plans to sell 2K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $50.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2026ACC: 0001950047-26-006073
Director
Since Jun 2021
2K
Shares to sell
$50.1K
Approx. market value
2K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
6/7/2023
702.00Restricted Stock
Not Applicable
6/29/2022
1.30KTotal acquired2K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/7/2023 | Restricted Stock Not Applicable | 702.00 | — |
6/29/2022 | Restricted Stock Not Applicable | 1.30K | — |
| Total | 2K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2K
Market value
$50.1K
6/15/2026
Total
Units
2K
Value
$50.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2026 | 2K | $50.1K | NASDAQ | Planned |
| Total | 2K | $50.1K | ||